Small molecule inhibitors of cancer stem cells and mesenchymal cancer types
US12263165B2 · kind B2 · utility
0Cited by
1References
1Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jul 11, 2023 |
| Grant date | Apr 1, 2025 |
| Priority date | — |
| Expiry date | Jul 11, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides compounds, their pharmaceutical compositions, and methods of their use for treating mesenchymally-derived or mesenchymally-transformed cancers, such as breast cancers and sarcomas, and for treating diseases or disorders that are characterized by the expression of vimentin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.